A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat (Q66083794)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat |
clinical trial |
Statements
Phase Ib, Open-label, Multi-center Study to Characterize the Safety, Tolerability and Pharmacodynamics (PD) of PDR001 in Combination With LCL161, Everolimus (RAD001) or Panobinostat (LBH589) (English)
0 references
14 October 2016
0 references
15 November 2019
0 references
400
0 references
18 year
0 references